|
Cholesterol Lowering and CV Risk: Meta-analyses
|
|
|
On-Treatment LDL and CHD Events in Statin Trials
|
|
|
Second Cycle of the CTT Meta-analysis: Proportional Effects on Major VascularEvents Per Mmol/L LDL-C Reduction
|
|
|
Second Cycle of the CTT Meta-analysis:More vs Less Statin—Proportional Effects onMajor Vascular Events Per Mmol/L LDL-C Reduction
|
|
|
Second Cycle of the CTT Meta-analysis: Statin vs Control—Proportional Effects onMajor Vascular Events Per Mmol/L LDL-C Reduction
|
|
|
Meta-analysis of Statin Trials and Fatal and Nonfatal Stroke
|
|
|
Meta-analysis of Statin Trials and Stroke Mortality
|
|
|
Stroke Risk and LDL Lowering inStatin Trials
|
|
Share this page with your colleagues and friends: